Under the agreement, Cambrex will manufacture and deliver Phase 3 and pre-launch quantities of the product candidate.
Depending on regulatory developments, the timing of completion of capacity expansion and meeting product delivery milestones, Cambrex is expected to reach $20m in 2013 revenues and potentially more in 2014.
Cambrex chief operating officer Shawn Cavanagh said the company is excited about successful execution of its capacity expansion so that it can help customer get the product candidate to market as quickly as possible.
"Our customers routinely cite our excellent quality systems, regulatory record and experienced personnel as reasons for awarding us business, and each of these factors played a role in Cambrex being chosen for this project," Cavanagh added.
"We continue to be excited about the pipeline of opportunities in front of us and are focused on making sure we have the resources in place to facilitate ongoing growth."